ID   HL-60/ara-C [USA 1984]
AC   CVCL_Z938
DR   cancercelllines; CVCL_Z938
DR   Wikidata; Q54889803
RX   PubMed=6091869;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 18
//
RX   PubMed=6091869;
RA   Bhalla K.N., Nayak R., Grant S.;
RT   "Isolation and characterization of a deoxycytidine kinase-deficient
RT   human promyelocytic leukemic cell line highly resistant to
RT   1-beta-D-arabinofuranosylcytosine.";
RL   Cancer Res. 44:5029-5037(1984).
//